Brief: UK'S MHRA Grants Marketing Authorisation For AUJEMFLU To Protect Adults Over 50 Against Flu
04/06/2026 17:11
BRIEF-UK'S MHRA Grants Marketing Authorisation For AUJEMFLU To Protect Adults Over 50 Against Flu June 4 (Reuters) - UK's MHRA:
UK'S MHRA: GRANTED MARKETING AUTHORISATION FOR ADJUVANTED TRIVALENT INFLUENZA VACCINE (AUJEMFLU) TO PROTECT ADULTS AGED 50 OVER AGAINST FLU
Further company coverage: CSL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Csl
See all newsEU Commission opens antitrust probe into Sanofi's flu vaccine campaign (updated)
EU Commission opens antitrust probe into Sanofi's flu vaccine campaign
Analysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
US military requires flu vaccine for some after outbreak in Texas training center
Corrected: BUZZ-Australian healthcare stocks hit a six-week high, acting as a primary hedge on ASX